Cisgender gay and bisexual men, transgender women, and transgender men remain at higher risk for HIV acquisition.
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
From an anal PrEP douche to the first women-controlled HIV prevention product, here's all the new HIV prevention products ...
Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...
News Medical on MSN2d
Affordability and supply remain critical to the success of long-lasting HIV drugAffordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are ...
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...
The AIDS Society of India (ASI) has urged the government to swiftly include HIV self-testing and pre-exposure prophylaxis (PrEP) in its healthcare policies and programs (). PrEP is a medication that ...
GlobalData on MSN2d
Gilead and MSD to advance once-weekly HIV treatment to Phase IIIThe companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.
Winnie Byanyima, from UNAIDS: ‘Lenacapavir is more effective than condoms or PrEP in prevention’
The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...
Harmony Garges, M.D, senior vice president, chief medical officer and head of global medical at ViiV Healthcare, highlighted ...
HIV Research for Prevention Conference ANALYSIS | SETHI NCUBE | The 5th HIV Research for Prevention Conference (HIVR4P 2024) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback